Global Gastric Motility Disorder Drug Sales Market Report 2017

December 2017 | 102 pages | ID: GEB2703DB90EN
QYResearch

Abstracts

In this report, the global Gastric Motility Disorder Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Gastric Motility Disorder Drug for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Gastric Motility Disorder Drug market competition by top manufacturers/players, with Gastric Motility Disorder Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Theravance, Inc.
• Helsinn Healthcare S.A.
• Concert Pharmaceuticals, Inc.
• Targacept, Inc.
• ChironWells GmbH

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Velusetrag
• Ipamorelin
• TD-8954
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Home Use

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Gastric Motility Disorder Drug Sales Market Report 2017

1 GASTRIC MOTILITY DISORDER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Gastric Motility Disorder Drug
1.2 Classification of Gastric Motility Disorder Drug by Product Category
  1.2.1 Global Gastric Motility Disorder Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Gastric Motility Disorder Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Velusetrag
  1.2.4 Ipamorelin
  1.2.5 TD-8954
  1.2.6 Others
1.3 Global Gastric Motility Disorder Drug Market by Application/End Users
  1.3.1 Global Gastric Motility Disorder Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Use
1.4 Global Gastric Motility Disorder Drug Market by Region
  1.4.1 Global Gastric Motility Disorder Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.3 China Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.4 Europe Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.5 Japan Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.7 India Gastric Motility Disorder Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Gastric Motility Disorder Drug (2012-2022)
  1.5.1 Global Gastric Motility Disorder Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL GASTRIC MOTILITY DISORDER DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Gastric Motility Disorder Drug Market Competition by Players/Suppliers
  2.1.1 Global Gastric Motility Disorder Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Gastric Motility Disorder Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Gastric Motility Disorder Drug (Volume and Value) by Type
  2.2.1 Global Gastric Motility Disorder Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Gastric Motility Disorder Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Gastric Motility Disorder Drug (Volume and Value) by Region
  2.3.1 Global Gastric Motility Disorder Drug Sales and Market Share by Region (2012-2017)
  2.3.2 Global Gastric Motility Disorder Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Gastric Motility Disorder Drug (Volume) by Application

3 UNITED STATES GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Gastric Motility Disorder Drug Sales and Value (2012-2017)
  3.1.1 United States Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Gastric Motility Disorder Drug Sales Price Trend (2012-2017)
3.2 United States Gastric Motility Disorder Drug Sales Volume and Market Share by Players
3.3 United States Gastric Motility Disorder Drug Sales Volume and Market Share by Type
3.4 United States Gastric Motility Disorder Drug Sales Volume and Market Share by Application

4 CHINA GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Gastric Motility Disorder Drug Sales and Value (2012-2017)
  4.1.1 China Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Gastric Motility Disorder Drug Sales Price Trend (2012-2017)
4.2 China Gastric Motility Disorder Drug Sales Volume and Market Share by Players
4.3 China Gastric Motility Disorder Drug Sales Volume and Market Share by Type
4.4 China Gastric Motility Disorder Drug Sales Volume and Market Share by Application

5 EUROPE GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Gastric Motility Disorder Drug Sales and Value (2012-2017)
  5.1.1 Europe Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Gastric Motility Disorder Drug Sales Price Trend (2012-2017)
5.2 Europe Gastric Motility Disorder Drug Sales Volume and Market Share by Players
5.3 Europe Gastric Motility Disorder Drug Sales Volume and Market Share by Type
5.4 Europe Gastric Motility Disorder Drug Sales Volume and Market Share by Application

6 JAPAN GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Gastric Motility Disorder Drug Sales and Value (2012-2017)
  6.1.1 Japan Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Gastric Motility Disorder Drug Sales Price Trend (2012-2017)
6.2 Japan Gastric Motility Disorder Drug Sales Volume and Market Share by Players
6.3 Japan Gastric Motility Disorder Drug Sales Volume and Market Share by Type
6.4 Japan Gastric Motility Disorder Drug Sales Volume and Market Share by Application

7 SOUTHEAST ASIA GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Gastric Motility Disorder Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Gastric Motility Disorder Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Gastric Motility Disorder Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Gastric Motility Disorder Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Gastric Motility Disorder Drug Sales Volume and Market Share by Application

8 INDIA GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Gastric Motility Disorder Drug Sales and Value (2012-2017)
  8.1.1 India Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Gastric Motility Disorder Drug Sales Price Trend (2012-2017)
8.2 India Gastric Motility Disorder Drug Sales Volume and Market Share by Players
8.3 India Gastric Motility Disorder Drug Sales Volume and Market Share by Type
8.4 India Gastric Motility Disorder Drug Sales Volume and Market Share by Application

9 GLOBAL GASTRIC MOTILITY DISORDER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Theravance, Inc.
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Helsinn Healthcare S.A.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Concert Pharmaceuticals, Inc.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Targacept, Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 ChironWells GmbH
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview

10 GASTRIC MOTILITY DISORDER DRUG MAUFACTURING COST ANALYSIS

10.1 Gastric Motility Disorder Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug
10.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Gastric Motility Disorder Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gastric Motility Disorder Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL GASTRIC MOTILITY DISORDER DRUG MARKET FORECAST (2017-2022)

14.1 Global Gastric Motility Disorder Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Gastric Motility Disorder Drug Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Gastric Motility Disorder Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Gastric Motility Disorder Drug Price and Trend Forecast (2017-2022)
14.2 Global Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Gastric Motility Disorder Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Gastric Motility Disorder Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Gastric Motility Disorder Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Gastric Motility Disorder Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2017-2022)
  14.3.2 Global Gastric Motility Disorder Drug Revenue Forecast by Type (2017-2022)
  14.3.3 Global Gastric Motility Disorder Drug Price Forecast by Type (2017-2022)
14.4 Global Gastric Motility Disorder Drug Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastric Motility Disorder Drug
Figure Global Gastric Motility Disorder Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Gastric Motility Disorder Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Velusetrag Product Picture
Figure Ipamorelin Product Picture
Figure TD-8954 Product Picture
Figure Others Product Picture
Figure Global Gastric Motility Disorder Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Gastric Motility Disorder Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure Global Gastric Motility Disorder Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Gastric Motility Disorder Drug Sales Volume (K Pcs) (2012-2017)
Table Global Gastric Motility Disorder Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Gastric Motility Disorder Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Gastric Motility Disorder Drug Sales Share by Players/Suppliers
Figure 2017 Gastric Motility Disorder Drug Sales Share by Players/Suppliers
Figure Global Gastric Motility Disorder Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Gastric Motility Disorder Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Gastric Motility Disorder Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Gastric Motility Disorder Drug Revenue Share by Players
Table 2017 Global Gastric Motility Disorder Drug Revenue Share by Players
Table Global Gastric Motility Disorder Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Gastric Motility Disorder Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Gastric Motility Disorder Drug by Type (2012-2017)
Figure Global Gastric Motility Disorder Drug Sales Growth Rate by Type (2012-2017)
Table Global Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Gastric Motility Disorder Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Type (2012-2017)
Figure Global Gastric Motility Disorder Drug Revenue Growth Rate by Type (2012-2017)
Table Global Gastric Motility Disorder Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Gastric Motility Disorder Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastric Motility Disorder Drug by Region (2012-2017)
Figure Global Gastric Motility Disorder Drug Sales Growth Rate by Region in 2016
Table Global Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Gastric Motility Disorder Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Region (2012-2017)
Figure Global Gastric Motility Disorder Drug Revenue Growth Rate by Region in 2016
Table Global Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Gastric Motility Disorder Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Region (2012-2017)
Figure Global Gastric Motility Disorder Drug Revenue Market Share by Region in 2016
Table Global Gastric Motility Disorder Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Gastric Motility Disorder Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Gastric Motility Disorder Drug by Application (2012-2017)
Figure Global Gastric Motility Disorder Drug Sales Market Share by Application (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Volume Market Share by Players in 2016
Table United States Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Volume Market Share by Type in 2016
Table United States Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Volume Market Share by Application in 2016
Figure China Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Gastric Motility Disorder Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Gastric Motility Disorder Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Gastric Motility Disorder Drug Sales Volume Market Share by Players (2012-2017)
Figure China Gastric Motility Disorder Drug Sales Volume Market Share by Players in 2016
Table China Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Gastric Motility Disorder Drug Sales Volume Market Share by Type (2012-2017)
Figure China Gastric Motility Disorder Drug Sales Volume Market Share by Type in 2016
Table China Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Gastric Motility Disorder Drug Sales Volume Market Share by Application (2012-2017)
Figure China Gastric Motility Disorder Drug Sales Volume Market Share by Application in 2016
Figure Europe Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Gastric Motility Disorder Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Gastric Motility Disorder Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales Volume Market Share by Players in 2016
Table Europe Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Gastric Motility Disorder Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales Volume Market Share by Type in 2016
Table Europe Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Gastric Motility Disorder Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales Volume Market Share by Application in 2016
Figure Japan Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Gastric Motility Disorder Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Gastric Motility Disorder Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Gastric Motility Disorder Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Gastric Motility Disorder Drug Sales Volume Market Share by Players in 2016
Table Japan Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Gastric Motility Disorder Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Gastric Motility Disorder Drug Sales Volume Market Share by Type in 2016
Table Japan Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Gastric Motility Disorder Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Gastric Motility Disorder Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Gastric Motility Disorder Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Gastric Motility Disorder Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Gastric Motility Disorder Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Gastric Motility Disorder Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Gastric Motility Disorder Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Gastric Motility Disorder Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Gastric Motility Disorder Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Gastric Motility Disorder Drug Sales Volume Market Share by Application in 2016
Figure India Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Gastric Motility Disorder Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Gastric Motility Disorder Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Gastric Motility Disorder Drug Sales Volume Market Share by Players (2012-2017)
Figure India Gastric Motility Disorder Drug Sales Volume Market Share by Players in 2016
Table India Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Gastric Motility Disorder Drug Sales Volume Market Share by Type (2012-2017)
Figure India Gastric Motility Disorder Drug Sales Volume Market Share by Type in 2016
Table India Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Gastric Motility Disorder Drug Sales Volume Market Share by Application (2012-2017)
Figure India Gastric Motility Disorder Drug Sales Volume Market Share by Application in 2016
Table Theravance, Inc. Basic Information List
Table Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Sales Global Market Share (2012-2017
Figure Theravance, Inc. Gastric Motility Disorder Drug Revenue Global Market Share (2012-2017)
Table Helsinn Healthcare S.A. Basic Information List
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales Global Market Share (2012-2017
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Revenue Global Market Share (2012-2017)
Table Concert Pharmaceuticals, Inc. Basic Information List
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales Global Market Share (2012-2017
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Revenue Global Market Share (2012-2017)
Table Targacept, Inc. Basic Information List
Table Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Sales Global Market Share (2012-2017
Figure Targacept, Inc. Gastric Motility Disorder Drug Revenue Global Market Share (2012-2017)
Table ChironWells GmbH Basic Information List
Table ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Sales Global Market Share (2012-2017
Figure ChironWells GmbH Gastric Motility Disorder Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Motility Disorder Drug
Figure Manufacturing Process Analysis of Gastric Motility Disorder Drug
Figure Gastric Motility Disorder Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastric Motility Disorder Drug Major Players in 2016
Table Major Buyers of Gastric Motility Disorder Drug
Table Distributors/Traders List
Figure Global Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Gastric Motility Disorder Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Gastric Motility Disorder Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Gastric Motility Disorder Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Gastric Motility Disorder Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Gastric Motility Disorder Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Gastric Motility Disorder Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Gastric Motility Disorder Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Gastric Motility Disorder Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Gastric Motility Disorder Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources